Pinz Capital Management, LP Kymera Therapeutics, Inc. Transaction History

Pinz Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$47.8 - $66.66 $19,120 - $26,664	-400 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $12,432 - $20,780	400 New	400 $19,000
Q4 2020 Feb 16, 2021	SELL	$28.07 - $87.83 $611,926 - $1.91 Million	-21,800 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $568,980 - $725,504	21,800 New	21,800 $704,000

186

65.6M

49.6K

17K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $1.78B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Pinz Capital Management, LP with notifications on news.